Skip to main content
Equibles
QTTB logo

QTTB · Q32 Bio Inc. · Metrics

Track QTTB — free

Use QTTB with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research QTTB.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$8.45 -0.20 (-2.31%)
Rebalance outlook locked
Market Cap
$257.51M
Shares
29.77M
Volume · Oct 26 563.7K Avg daily vol (3M) 711.36K

QTTB metrics

67 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$8.65
Market cap
$257.51M

Price action

20 metrics
Price change (1W)
+15.0%
Price change (30D)
-6.3%
Price change (3M)
-42.9%
Price change (6M)
+39.1%
Price change (YTD)
+160.5%
Price change (1Y)
+208.9%
Trailing year
Price change (5Y)
—
52-week high
$21.38
52-week low
$1.93
Change from 52-week high
-59.5%
Change from 52-week low
+348.2%
Annualized volatility
171.5%
Annualized volatility (3M)
64.2%
Beta
-0.1
RSI (14D)
43.8
Price vs SMA 50
-22.3%
Price vs SMA 200
-5.0%
Avg volume (3M)
711,359
Relative volume
0.6
Average dollar volume
$7.75M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
29.77M

Valuation

12 metrics
P / E (TTM)
2.8
Trailing earnings · reciprocal yield 36.1%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
2.4
reciprocal yield 41.1%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
13.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-13

Profitability

9 metrics
Gross margin
—
Operating margin
31.5%
Trailing 12 months
Net margin
55.5%
Gross profit (TTM)
—
Operating profit (TTM)
$21.46M
Net income (TTM)
$33.79M
Trailing 12 months
Diluted EPS (TTM)
$3.12
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.00
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$2.02
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$2.99
Operating cash flow per diluted share (TTM)
$-1.44
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$0.99
Stock compensation per diluted share (TTM)
$0.41
Book value per share
$3.27

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
$0
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+66.8%
Year over year · more shares
Revenue CAGR (3Y)
+155.9%
Revenue CAGR (5Y)
+81.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
31.9%
Return on assets
29.2%
Debt / equity
—
Current ratio
20.3
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
20.3
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$106.27M
Latest balance sheet
Cash & equivalents
$106.27M
Total assets
$115.87M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$19.83M
Capital expenditures (TTM)
—
R&D (TTM)
$14.35M
SG&A (TTM)
—
Stock compensation (TTM)
$5.88M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
72
13F filer change QoQ
+18
Institutional ownership
75.4%
Conviction holders (share of 13F filers)
4.2%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+141.9%
Holder tenure
4.3
Price vs estimated holder cost
+61.1%

Ownership (registered funds)

1 metrics
Index-fund ownership
2.1%

Short interest

3 metrics
Short interest
15.7%
Latest settlement · 4.3 days to cover
Days to cover
4.3d
Short-squeeze score
75 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$320,396
Insider-sentiment score
26 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1661998 CUSIP 746964105 13F (30d) 3 filings 3 filers Visit website Investor relations